Avasara Finance Rights Issue Jan 2026 vs Dr Lalchandani Labs Rights Issue 2026

Comparison between Avasara Finance Rights Issue Jan 2026 and Dr Lalchandani Labs Rights Issue 2026.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Avasara Finance Rights Issue Jan 2026 and Dr Lalchandani Labs Rights Issue 2026. Avasara Finance Rights Issue Jan 2026 is listed on BSE while Dr Lalchandani Labs Rights Issue 2026 is listed on BSE.

 Avasara Finance LtdDr Lalchandani Labs Ltd
LogoAvasara Finance Rights Issue Jan 2026 LogoDr Lalchandani Labs Rights Issue 2026 Logo
Listing AtBSEBSE
Terms of Payment

The entire Rights Issue Price will be payable at the time of making the application in the Issue.

The entire Issue Price of Rs.10/- per share is payable on Application.

Entitlement2 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date1 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarPurva Sharegistry (India) Pvt.Ltd.Cameo Corporate Services Ltd.
Lead Managers

Rights Issue Size and Price

The issue size of Avasara Finance Rights Issue Jan 2026 rights issue is ₹10.00 Crores, whereas Dr Lalchandani Labs Rights Issue 2026 rights issue size is ₹4.33 Crores.

 Avasara Finance LtdDr Lalchandani Labs Ltd
Issue Size1,00,01,800 shares43,32,000 shares
Issue Size (Amount)₹10.00 Crores₹4.33 Crores
Issue Price₹10 per share₹10 per share
Face Value₹10 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Avasara Finance Rights Issue Jan 2026 is Jan 01, 2026 while record date of Dr Lalchandani Labs Rights Issue 2026 is Jan 27, 2026.

 Avasara Finance LtdDr Lalchandani Labs Ltd
Record DateJan 01, 2026Jan 27, 2026
Credit of Rights EntitlementsJan 02, 2026Feb 02, 2026
Bid/Offer Opens OnJan 09, 2026Feb 04, 2026
Renunciation of Rights EntitlementsJan 14, 2026Feb 24, 2026
Bid/Offer Closes OnJan 20, 2026Feb 27, 2026
Deemed Date of AllotmentJan 21, 2026Feb 23, 2026
Credit DateJan 22, 2026Feb 24, 2026
Listing DateJan 23, 2026Feb 25, 2026

Financials details

Comparison of Avasara Finance Rights Issue Jan 2026 and Dr Lalchandani Labs Rights Issue 2026 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Avasara Finance LtdDr Lalchandani Labs Ltd
Financial

Company Financials (Restated Consolidated)

Period Ended31 Mar 202531 Mar 2024
Assets2.483.06
Total Income1.33
Profit After Tax-0.450.22
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended31 Mar 202531 Mar 2024
Total Income4.465.05
Profit After Tax0.400.62
NET Worth9.969.54
Reserves and Surplus5.625.21
Amount in ₹ Crore

Compare with others

Compare:

Avasara Finance Rights Issue Jan 2026 Vs Dr Lalchandani Labs Rights Issue 2026